These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12582462)

  • 1. Somatostatin analogues as drug therapies for retinopathies.
    Grant MB; Caballero S
    Drugs Today (Barc); 2002 Nov; 38(11):783-91. PubMed ID: 12582462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic problem of proliferative diabetic retinopathy: targeting somatostatin receptors.
    Davis MI; Wilson SH; Grant MB
    Horm Metab Res; 2001 May; 33(5):295-9. PubMed ID: 11440276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of long-acting somatostatin analogue treatment in diabetic retinopathy.
    Boehm BO
    Dev Ophthalmol; 2007; 39():111-121. PubMed ID: 17245082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of diabetic retinopathy with somatostatin analogues].
    Lang GE
    Ophthalmologe; 2004 Mar; 101(3):290-3. PubMed ID: 15007609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical treatment of diabetic retinopathy with somatostatin analogues.
    Palii SS; Caballero S; Shapiro G; Grant MB
    Expert Opin Investig Drugs; 2007 Jan; 16(1):73-82. PubMed ID: 17155855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of octreotide in the treatment of diabetic retinopathy.
    Grant MB; Caballero S
    Treat Endocrinol; 2005; 4(4):199-203. PubMed ID: 16053337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus and retinopathy.
    Gargiulo P; Giusti C; Pietrobono D; La Torre D; Diacono D; Tamburrano G
    Dig Liver Dis; 2004 Feb; 36 Suppl 1():S101-5. PubMed ID: 15077918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2.
    Dal Monte M; Ristori C; Cammalleri M; Bagnoli P
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3596-606. PubMed ID: 19324858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy.
    Wilkinson-Berka JL; Wraight C; Werther G
    Curr Med Chem; 2006; 13(27):3307-17. PubMed ID: 17168853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?
    Spranger J; Möhlig M; Osterhoff M; Bühnen J; Blum WF; Pfeiffer AF
    Horm Metab Res; 2001 May; 33(5):312-6. PubMed ID: 11440279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonpeptide somatostatin receptor agonists specifically target ocular neovascularization via the somatostatin type 2 receptor.
    Palii SS; Afzal A; Shaw LC; Pan H; Caballero S; Miller RC; Jurczyk S; Reubi JC; Tan Y; Hochhaus G; Edelhauser H; Geroski D; Shapiro G; Grant MB
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5094-102. PubMed ID: 18599562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic effects of somatostatin analogues.
    García de la Torre N; Wass JA; Turner HE
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):425-41. PubMed ID: 12354124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does laser still have a role in the management of retinal vascular and neovascular diseases?
    Shah AM; Bressler NM; Jampol LM
    Am J Ophthalmol; 2011 Sep; 152(3):332-339.e1. PubMed ID: 21742309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of somatostatin receptor ligands in obesity and diabetic complications.
    Boehm BO; Lustig RH
    Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):493-509. PubMed ID: 12079271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment.
    Tremolada G; Del Turco C; Lattanzio R; Maestroni S; Maestroni A; Bandello F; Zerbini G
    Exp Diabetes Res; 2012; 2012():728325. PubMed ID: 22566995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin in diabetic retinopathy.
    Croxen R; Baarsma GS; Kuijpers RW; van Hagen PM
    Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():518-24. PubMed ID: 16444186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin analogs inhibit neonatal retinal neovascularization.
    Higgins RD; Yan Y; Schrier BK
    Exp Eye Res; 2002 May; 74(5):553-9. PubMed ID: 12076076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
    Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
    Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a Randomized Clinical Trial of Aflibercept vs Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Is It Time to Retire Your Laser?
    Glassman AR
    JAMA Ophthalmol; 2017 Jul; 135(7):685-686. PubMed ID: 28570733
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of modulation of GH/IGF-I axis in the development of diabetic proliferative retinopathy.
    Genovese S; Riccardi G
    J Endocrinol Invest; 2003; 26(8 Suppl):114-6. PubMed ID: 15233225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.